CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2017 EXECUTIVE SUMMARY
Autores:
Alan J. Garber, MD, PhD, FACE1; Martin J. Abrahamson, MD2; Joshua I. Barzilay, MD, FACE3;
Lawrence Blonde, MD, FACP, FACE4; Zachary T. Bloomgarden, MD, MACE5;
Michael A. Bush, MD6; Samuel Dagogo-Jack, MD, FACE7; Ralph A. DeFronzo, MD8;
Daniel Einhorn, MD, FACP, FACE9; Vivian A. Fonseca, MD, FACE10;
Jeffrey R. Garber, MD, FACP, FACE11; W. Timothy Garvey, MD, FACE12;
George Grunberger, MD, FACP, FACE13; Yehuda Handelsman, MD, FACP, FNLA, FACE14;
Irl B. Hirsch, MD15; Paul S. Jellinger, MD, MACE16; Janet B. McGill, MD, FACE17;
Jeffrey I. Mechanick, MD, FACN, FACP, FACE, ECNU18;
Paul D. Rosenblit, MD, PhD, FNLA, FACE19; Guillermo E. Umpierrez, MD, FACP, FACE20
Descarga el artículo
